The following set of principles guides decision-making that addresses both national security and public health needs in response to seasonal and pandemic influenza on a timely, cost-effective, reliable, and sustainable basis. These guiding principles describe the characteristics that aim to modernize domestic manufacturing capacities; spark innovative vaccine technology; foster rigorous research and development; and promote vaccine coverage across populations. Ultimately, the capacity and capabilities developed for influenza preparedness would enable the USG to respond more effectively to other emerging infectious diseases.
Expand Public-Private Partnerships
An inclusive approach will be used to expand public-private partnerships, including researchers, developers, SLTT governments, manufacturers, regulators, purchasers, policy makers, and international stakeholders to monitor the impact of influenza, bring new and improved vaccines and other medical countermeasures (MCMs) to market, and facilitate increased immunization.
Promote a Financially Sound Pathway
Public funding should leverage private investment to sustain the seasonal influenza vaccine market, which in turn will support pandemic response needs, precipitate innovation, and expand opportunities for all sectors.
Increase Public Education, Awareness, Engagement, and Access
Communicating vaccine effectiveness and encouraging annual influenza immunization using evidence-based and scientifically sound methodologies are essential to increase public trust in vaccines and influenza vaccination rates.
<< Previous ---------
Top of Page ---------
Next >>
